[HTML][HTML] Regulation of bone mass by Wnt signaling

V Krishnan, HU Bryant… - The Journal of clinical …, 2006 - Am Soc Clin Investig
Wnt proteins are a family of secreted proteins that regulate many aspects of cell growth,
differentiation, function, and death. Considerable progress has been made in our understanding …

Molecular determinants of tissue selectivity in estrogen receptor modulators

TA Grese, JP Sluka, HU Bryant… - Proceedings of the …, 1997 - National Acad Sciences
Interaction of the estrogen receptor/ligand complex with a DNA estrogen response element
is known to regulate gene transcription. In turn, specific conformations of the receptor-ligand …

Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene:  A Novel, Highly Potent, Selective Estrogen …

…, GJ Cullinan, TR Pell, HU Bryant - Journal of medicinal …, 1997 - ACS Publications
Raloxifene, [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone
hydrochloride (2), is representative of a class of compounds known as …

Orally bioavailable GSK‐3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo

…, TJ Martin, M Sato, HU Bryant… - Journal of Bone and …, 2006 - academic.oup.com
GSK‐3, a component of the canonical Wnt signaling pathway, is implicated in regulation of
bone mass. The effect of a small molecule GSK‐3 inhibitor was evaluated in pre‐osteoblasts …

Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats

M Sato, MK Rippy, HU Bryant - The FASEB Journal, 1996 - Wiley Online Library
For the first time, four well‐charac‐ terized compounds from four distinct chemical classes were
directly compared for efficacy and potency in bone, uteri, lipids, and adipose tissues in an …

Selective estrogen receptor modulators: an alternative to hormone replacement therapy

HU Bryant, WH Dere - Proceedings of the Society for …, 1998 - journals.sagepub.com
Estrogen is a key regulatory hormone, which in addition to its role in reproduction, affects a
number of physiological systems, including the skeleton and cardiovascular system. The …

Structure− activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene

…, LL Short, AL Glasebrook, HU Bryant - Journal of medicinal …, 1997 - ACS Publications
The 2-arylbenzothiophene raloxifene, 1, is a selective estrogen receptor modulator which is
currently under clinical evaluation for the prevention and treatment of postmenopausal …

Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen-or raloxifene-mediated bone …

NN Yang, HU Bryant, S Hardikar, M Sato… - …, 1996 - academic.oup.com
Estrogen or raloxifene (LY156758) prevent estrogen deficiency-induced bone loss in animals
and humans. We demonstrated in the rat that a 22% reduction in bone mineral density …

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators

…, M Sato, AL Glasebrook, HU Bryant - Journal of medicinal …, 1998 - ACS Publications
The 2-arylbenzothiophene raloxifene, 1, is a selective estrogen receptor modulator (SERM)
which is currently under clinical evaluation for the prevention and treatment of …

Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat

…, DL Phillips, M Sato, LL Short, HU Bryant - The Journal of steroid …, 1996 - Elsevier
Representative non-steroidal estrogens, from common environmental sources such as plants,
pesticides, surfactants, plastics, and animal health products, demonstrated an ability to …